BIOMAT Database Logo BIOMAT Database Logo

Effect of cefamandole, cefuroxime and cefoxitin on yeast fecal flora of surgical patients. 1998

N Thomakos, and S Maraki, and T Liakakos, and A Macheras, and S Kanavaki, and E Marinis, and M Sehas, and A N Margioris, and G Samonis
3rd Department of Surgery, University of Athens, 'Sotiria' Hospital, Athens, Greece.

Aim of the present study was to evaluate the effect of cefamandole, cefuroxime and cefoxitin on the level of gastrointestinal (GI) colonization by Candida albicans in humans. Twenty-eight adult patients received one of these three cephalosporins for 10 days, as treatment of infection, and were studied prospectively. Quantitative stool cultures for yeasts were performed immediately before, at the end, and 1 week after discontinuation of treatment. All three antibiotics caused an increase of the yeast concentration in the fecal flora. The increase caused by cefoxitin was the highest (2.5 log10 CFU/g of stool). Our results suggest that the cephalosporins tested cause minor increases of the colonization of the GI tract by C. albicans.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D002435 Cefamandole Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate. Cephamandole,Compound 83405
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D002444 Cefuroxime Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS. Cephuroxime,Ketocef,Zinacef
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics

Related Publications

N Thomakos, and S Maraki, and T Liakakos, and A Macheras, and S Kanavaki, and E Marinis, and M Sehas, and A N Margioris, and G Samonis
Cefamandole, cefuroxime and cefoxitin.
April 1979, Drug and therapeutics bulletin,
N Thomakos, and S Maraki, and T Liakakos, and A Macheras, and S Kanavaki, and E Marinis, and M Sehas, and A N Margioris, and G Samonis
[3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
December 1981, Revue medicale de la Suisse romande,
N Thomakos, and S Maraki, and T Liakakos, and A Macheras, and S Kanavaki, and E Marinis, and M Sehas, and A N Margioris, and G Samonis
Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
January 1978, Scandinavian journal of infectious diseases. Supplementum,
N Thomakos, and S Maraki, and T Liakakos, and A Macheras, and S Kanavaki, and E Marinis, and M Sehas, and A N Margioris, and G Samonis
Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime.
April 1979, Antimicrobial agents and chemotherapy,
N Thomakos, and S Maraki, and T Liakakos, and A Macheras, and S Kanavaki, and E Marinis, and M Sehas, and A N Margioris, and G Samonis
The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
January 1984, Clinical therapeutics,
N Thomakos, and S Maraki, and T Liakakos, and A Macheras, and S Kanavaki, and E Marinis, and M Sehas, and A N Margioris, and G Samonis
Cefamandole and cefoxitin.
July 1985, Annals of internal medicine,
N Thomakos, and S Maraki, and T Liakakos, and A Macheras, and S Kanavaki, and E Marinis, and M Sehas, and A N Margioris, and G Samonis
Cefamandole and cefoxitin.
February 1979, The Medical letter on drugs and therapeutics,
N Thomakos, and S Maraki, and T Liakakos, and A Macheras, and S Kanavaki, and E Marinis, and M Sehas, and A N Margioris, and G Samonis
Lack of in vitro activity of cefoxitin, cefamandole, cefuroxime, and piperacillin against Chlamydia trachomatis.
February 1982, Antimicrobial agents and chemotherapy,
N Thomakos, and S Maraki, and T Liakakos, and A Macheras, and S Kanavaki, and E Marinis, and M Sehas, and A N Margioris, and G Samonis
Effect of frusemide on the elimination of cefuroxime and cefoxitin.
May 1980, The Journal of antimicrobial chemotherapy,
N Thomakos, and S Maraki, and T Liakakos, and A Macheras, and S Kanavaki, and E Marinis, and M Sehas, and A N Margioris, and G Samonis
Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.
January 1983, Infection,
Copied contents to your clipboard!